# eFFECTOR Therapeutics, Inc. (EFTR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/EFTR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -9.29M | $ -7.65M | $ 20.25M | $ 827.0K |
| 2023 | $ 175.2K | $ -38.72M | $ -32.06M | $ 20.55M | $ -5.80M |
| 2022 | $ 2.25M | $ -25.32M | $ -29.15M | $ 20.28M | $ 3.90M |
| 2021 | $ 3.03M | $ 18.78M | $ -29.63M | $ 20.03M | $ 17.28M |
| 2020 | $ 53.51M | $ 211.5K | $ 17.43M | $ 12.96M | $ -132.25M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 24.48 |
| Liabilities / Eq | 31.81 |
| Current Ratio | 1.03 |

## Other views

- [Metrics](https://sponda.capital/en/EFTR.md)
- [Charts](https://sponda.capital/en/EFTR/charts.md)
- [Compare](https://sponda.capital/en/EFTR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.